Literature DB >> 16476056

Induction of autoimmunity by immunization with hapten-modified hen egg lysozyme in hen egg lysozyme-transgenic mice.

Hee-Kap Kang1, Yun Jo Chung, Chung Ung Park, Yong-Suk Jang, Byung S Kim.   

Abstract

To understand the mechanism of autoimmunity induction, hen egg lysozyme (HEL)-transgenic (Tg) C57BL/6 (B6) mice were immunized with HEL or phosphorylcholine-conjugated HEL (PC-HEL). Repeated immunization of HEL-Tg mice with native HEL failed to induce the antibody response against HEL. However, immunization with PC-HEL generated a significant anti-HEL antibody response. Immunization of the Tg mice with dominant (HEL(74-88)) or cryptic (HEL(47-61)) T-cell epitope peptide stimulated the corresponding T-cell response and similarly yielded the anti-HEL antibody response. Predominance of immunoglobulin G1 (IgG1) anti-HEL antibody response in the HEL-Tg mice and preferential IL-4 production by HEL-specific T cells suggested the dependency of the antibody response to the presence of T helper 2. HEL-Tg mice received HEL-primed B6 T cells, but not HEL-primed Tg T cells, were able to generate anti-HEL antibody response following PC-HEL immunization. The pattern and the level of epitope peptides generated by splenic antigen-presenting cells indicated that PC-HEL results in much more efficient processing as compared to HEL. These results strongly suggest that the enhancement of antigen processing by hapten (PC) conjugation to the antigen facilitates more efficient stimulation of T cells reactive to self antigen, HEL in HEL-Tg mice resulting in the production of anti-self HEL antibody.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476056      PMCID: PMC1782231          DOI: 10.1111/j.1365-2567.2005.02310.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  35 in total

Review 1.  DNA vaccines: immunology, application, and optimization*.

Authors:  S Gurunathan; D M Klinman; R A Seder
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase.

Authors:  H S Hiemstra; N C Schloot; P A van Veelen; S J Willemen; K L Franken; J J van Rood; R R de Vries; A Chaudhuri; P O Behan; J W Drijfhout; B O Roep
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

3.  Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak.

Authors:  C A Nelson; R W Roof; D W McCourt; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

4.  Peptides identified through phage display direct immunogenic antigen to dendritic cells.

Authors:  Tyler J Curiel; Cindy Morris; Michael Brumlik; Samuel J Landry; Kristiaan Finstad; Anne Nelson; Virendra Joshi; Christopher Hawkins; Xavier Alarez; Andrew Lackner; Mansour Mohamadzadeh
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

Review 5.  Progress on new vaccine strategies for the immunotherapy and prevention of cancer.

Authors:  Jay A Berzofsky; Masaki Terabe; SangKon Oh; Igor M Belyakov; Jeffrey D Ahlers; John E Janik; John C Morris
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

6.  Modification of the inhibitory amino acid for epitope peptide binding onto major histocompatibility complex class II molecules enhances immunogenicity of the antigen.

Authors:  S-H Chang; J Kim; K-Y Lee; H-J Kim; Y J Chung; C U Park; B S Kim; Y-S Jang
Journal:  Scand J Immunol       Date:  2004-02       Impact factor: 3.487

7.  Antigen-specific B cells preferentially induce CD4+ T cells to produce IL-4.

Authors:  A E Macaulay; R H DeKruyff; C C Goodnow; D T Umetsu
Journal:  J Immunol       Date:  1997-05-01       Impact factor: 5.422

8.  GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes.

Authors:  Vissia Viglietta; Sally C Kent; Tihamer Orban; David A Hafler
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

9.  A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

Authors:  Zhuhui Huang; Subbiah Elankumaran; Abdul S Yunus; Siba K Samal
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

Review 10.  Cancer immunotherapy: a treatment for the masses.

Authors:  Joseph N Blattman; Philip D Greenberg
Journal:  Science       Date:  2004-07-09       Impact factor: 47.728

View more
  2 in total

1.  Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.

Authors:  M Benjamin Hock; Karen E Thudium; Montserrat Carrasco-Triguero; Nikolai F Schwabe
Journal:  AAPS J       Date:  2014-11-08       Impact factor: 4.009

Review 2.  Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.

Authors:  Dan A Erkes; Senthamil R Selvan
Journal:  J Immunol Res       Date:  2014-05-15       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.